Meeting
2015 ASCO Annual Meeting
Transcriptomic and protein expression analysis of helicase antigen (HAGE) in triple negative breast cancer (TNBC) as a novel prognostic and predictive biomarker.
Authors
Tarek M. A. Abdel-Fatah
Nottingham University City Hospital NHS Trust, Nottingham, United Kingdom
Tarek M. A. Abdel-Fatah , Stephanie McArdle , Devika Agarwal , Paul M Moseley , Andrew R. Green , Graham Ball , A Graham Pockley , Ian O. Ellis , Robert Rees , Steve Y.T. Chan
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy
Track
Breast Cancer
Sub Track
Triple-Negative Breast Cancer
Citation
J Clin Oncol 33, 2015 (suppl; abstr 1093)
DOI
10.1200/jco.2015.33.15_suppl.1093
Abstract #
1093
Poster Bd #
207
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Phase II trial of nivolumab with chemotherapy as neoadjuvant treatment in inflammatory breast cancer.
First Author: Maryann J. Kwa
Poster
2015 ASCO Annual Meeting
Mechanistic and clinical analysis of Sperm associated antigen 5 (SPAG5) as a novel prognostic, predictive, actionable gene in Breast Cancer (BC).
First Author: Tarek M. A. Abdel-Fatah
Poster
2014 ASCO Annual Meeting
The role of CHFR as a predictive marker of response to taxane-based preoperative chemotherapy in triple-negative breast cancer.
First Author: Elisavet Paplomata
Poster
2013 ASCO Annual Meeting
Next-generation sequencing to find predictors for chemotherapy response in triple-negative breast cancer (TNBC).
First Author: Esther H. Lips